Urinary incontinence in patients receiving neuroleptics.
This paper presents a series of case reports making the observation of a possible association between neuroleptic drug therapy and urinary incontinence. The incontinence was limited and not of the overflow or stress variety. Anticholinergic compounds or drug action did not seem to influence or account for the findings. A central basis is postulated for consideration and warrants further study.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001921:Brain / Q000503:physiopathology; D002746:Chlorpromazine / Q000009:adverse effects; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy; D013888:Thiothixene / Q000009:adverse effects; D014549:Urinary Incontinence / Q000139:chemically induced* / Q000503:physiopathology
D014150:Antipsychotic Agents; D013888:Thiothixene; D008094:Lithium; D006220:Haloperidol; D005476:Fluphenazine; D002746:Chlorpromazine